Impact of prior biologic use on persistence of treatment in patients with psoriatic arthritis enrolled in the US Corrona registry View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2017-04

AUTHORS

Leslie R. Harrold, Bradley S. Stolshek, Sabrina Rebello, David H. Collier, Alex Mutebi, Sally W. Wade, Wendi Malley, Jeffrey D. Greenberg, Carol J. Etzel

ABSTRACT

Psoriatic arthritis (PsA) is a chronic condition characterized by a diverse set of symptoms, from swollen joints to nail disease to skin disease. A variety of treatment options are available, including tumor necrosis factor inhibitors (TNFis). Little is known about treatment persistence in patients with PsA who initiate TNFi therapy, with and without prior biologic use. This study assessed persistence in these subgroups of patients with PsA and identified factors associated with persistence. This retrospective study utilized data from the Corrona registry of patients with PsA-with or without prior biologic experience-who initiated TNFi therapy between October 1, 2002, and March 21, 2013. Kaplan-Meier curves estimated median time to nonpersistence (discontinuation or switch to another biologic). Cox proportional hazards models identified factors associated with TNFi nonpersistence. A total of 1241 TNFi initiations were identified: 549 by biologic-naïve and 692 by biologic-experienced patients. Through 4 years of follow-up, more biologic-naïve than biologic-experienced patients remained persistent. Biologic-naïve patients had a greater mean time to nonpersistence compared with biologic-experienced patients: 32 vs 23 months (p = 0.0002). Moderate and high disease activities based on clinical disease activity index and disease duration were associated with persistence in both biologic-naïve and biologic-experienced patients. Additionally, in the biologic-experienced patients, the number of prior medications and skin disease were associated with persistence. The majority of patients with PsA in this study were persistent with their TNFi therapy; biologic-naïve patients had greater persistence compared with biologic-experienced patients. Predictors of persistence differed slightly between biologic-naïve and biologic-experienced patients. More... »

PAGES

895-901

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s10067-017-3593-x

DOI

http://dx.doi.org/10.1007/s10067-017-3593-x

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1084023725

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/28271234


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Clinical Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adult", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Antirheumatic Agents", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Arthritis, Psoriatic", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Biological Products", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Disease Progression", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Kaplan-Meier Estimate", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Middle Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Proportional Hazards Models", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Registries", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Retrospective Studies", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Severity of Illness Index", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Time Factors", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Treatment Outcome", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Tumor Necrosis Factor-alpha", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "United States", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "University of Massachusetts Medical School", 
          "id": "https://www.grid.ac/institutes/grid.168645.8", 
          "name": [
            "Corrona, LLC, 325 Turnpike Road, Suite 325, 01772, Southborough, MA, USA", 
            "Department of Medicine, University of Massachusetts Medical School, AC7-201, 55 Lake Avenue North, 01655, Worcester, MA, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Harrold", 
        "givenName": "Leslie R.", 
        "id": "sg:person.0736771744.12", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0736771744.12"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Amgen (United States)", 
          "id": "https://www.grid.ac/institutes/grid.417886.4", 
          "name": [
            "Amgen Inc., One Amgen Center Drive, 91320, Thousand Oaks, CA, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Stolshek", 
        "givenName": "Bradley S.", 
        "id": "sg:person.01047467057.99", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01047467057.99"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Corrona, LLC, 325 Turnpike Road, Suite 325, 01772, Southborough, MA, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Rebello", 
        "givenName": "Sabrina", 
        "id": "sg:person.014625266551.18", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014625266551.18"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Amgen (United States)", 
          "id": "https://www.grid.ac/institutes/grid.417886.4", 
          "name": [
            "Amgen Inc., One Amgen Center Drive, 91320, Thousand Oaks, CA, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Collier", 
        "givenName": "David H.", 
        "id": "sg:person.0643276502.79", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0643276502.79"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Amgen (United States)", 
          "id": "https://www.grid.ac/institutes/grid.417886.4", 
          "name": [
            "Amgen Inc., One Amgen Center Drive, 91320, Thousand Oaks, CA, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Mutebi", 
        "givenName": "Alex", 
        "id": "sg:person.0747353025.27", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0747353025.27"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Wade Outcomes Research and Consulting, 136 U Street, 84103, Salt Lake City, UT, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Wade", 
        "givenName": "Sally W.", 
        "id": "sg:person.0617012057.00", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0617012057.00"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Corrona, LLC, 325 Turnpike Road, Suite 325, 01772, Southborough, MA, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Malley", 
        "givenName": "Wendi", 
        "id": "sg:person.014200421247.34", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014200421247.34"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "New York University", 
          "id": "https://www.grid.ac/institutes/grid.137628.9", 
          "name": [
            "Corrona, LLC, 325 Turnpike Road, Suite 325, 01772, Southborough, MA, USA", 
            "New York University School of Medicine, 301 East 17th Street, Suite 1410, 10003, New York, NY, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Greenberg", 
        "givenName": "Jeffrey D.", 
        "id": "sg:person.014444070377.20", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014444070377.20"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Corrona, LLC, 325 Turnpike Road, Suite 325, 01772, Southborough, MA, USA", 
            "Department of Epidemiology, University of Texas, MD Anderson Cancer Center, Houston, TX, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Etzel", 
        "givenName": "Carol J.", 
        "id": "sg:person.01257177671.69", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01257177671.69"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "https://doi.org/10.1093/rheumatology/ken034", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1000685889"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1136/ard.2004.032482", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1002609767"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1136/annrheumdis-2013-205056", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1004467907"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/art.37917", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1004625809"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1186/1471-2474-12-204", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1007982993", 
          "https://doi.org/10.1186/1471-2474-12-204"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/nrrheum.2015.8", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1008800983", 
          "https://doi.org/10.1038/nrrheum.2015.8"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/maj.0b013e3181e8bcb0", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1009052293"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/maj.0b013e3181e8bcb0", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1009052293"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1186/s13075-015-0697-z", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1012494697", 
          "https://doi.org/10.1186/s13075-015-0697-z"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1186/s13075-015-0697-z", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1012494697", 
          "https://doi.org/10.1186/s13075-015-0697-z"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1186/ar1881", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1013480577", 
          "https://doi.org/10.1186/ar1881"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1136/annrheumdis-2015-208337", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1022767391"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1136/rmdopen-2015-000181", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1023074542"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1136/rmdopen-2015-000181", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1023074542"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1155/2012/176298", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1029767398"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/acr.20643", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1030584108"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/rheumatology/keq325", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1038859738"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.jaad.2005.03.046", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1038933125"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1186/1471-2474-10-91", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1039263381", 
          "https://doi.org/10.1186/1471-2474-10-91"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/art.37876", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1042418966"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/acr.22377", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1044199186"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.2147/ppa.s77053", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1046367370"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.jaad.2008.02.040", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1050660676"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.3109/14397595.2013.872862", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1052494762"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1186/ar3249", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1053673056", 
          "https://doi.org/10.1186/ar3249"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.sder.2010.01.004", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1054747839"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.3899/jrheum.080691", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1071541588"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.5312/wjo.v5.i4.537", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1072758487"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1077512807", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1078223595", 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2017-04", 
    "datePublishedReg": "2017-04-01", 
    "description": "Psoriatic arthritis (PsA) is a chronic condition characterized by a diverse set of symptoms, from swollen joints to nail disease to skin disease. A variety of treatment options are available, including tumor necrosis factor inhibitors (TNFis). Little is known about treatment persistence in patients with PsA who initiate TNFi therapy, with and without prior biologic use. This study assessed persistence in these subgroups of patients with PsA and identified factors associated with persistence. This retrospective study utilized data from the Corrona registry of patients with PsA-with or without prior biologic experience-who initiated TNFi therapy between October 1, 2002, and March 21, 2013. Kaplan-Meier curves estimated median time to nonpersistence (discontinuation or switch to another biologic). Cox proportional hazards models identified factors associated with TNFi nonpersistence. A total of 1241 TNFi initiations were identified: 549 by biologic-na\u00efve and 692 by biologic-experienced patients. Through 4\u00a0years of follow-up, more biologic-na\u00efve than biologic-experienced patients remained persistent. Biologic-na\u00efve patients had a greater mean time to nonpersistence compared with biologic-experienced patients: 32 vs 23\u00a0months (p\u00a0=\u00a00.0002). Moderate and high disease activities based on clinical disease activity index and disease duration were associated with persistence in both biologic-na\u00efve and biologic-experienced patients. Additionally, in the biologic-experienced patients, the number of prior medications and skin disease were associated with persistence. The majority of patients with PsA in this study were persistent with their TNFi therapy; biologic-na\u00efve patients had greater persistence compared with biologic-experienced patients. Predictors of persistence differed slightly between biologic-na\u00efve and biologic-experienced patients.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1007/s10067-017-3593-x", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": true, 
    "isPartOf": [
      {
        "id": "sg:journal.1093299", 
        "issn": [
          "0770-3198", 
          "1434-9949"
        ], 
        "name": "Clinical Rheumatology", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "4", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "36"
      }
    ], 
    "name": "Impact of prior biologic use on persistence of treatment in patients with psoriatic arthritis enrolled in the US Corrona registry", 
    "pagination": "895-901", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "725b50650bd89c583700db80e703ff71d4397ef69eb5c17ff2fc18958c3c7899"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "28271234"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "8211469"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s10067-017-3593-x"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1084023725"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s10067-017-3593-x", 
      "https://app.dimensions.ai/details/publication/pub.1084023725"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-11T09:38", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000346_0000000346/records_99832_00000003.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://link.springer.com/10.1007%2Fs10067-017-3593-x"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s10067-017-3593-x'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s10067-017-3593-x'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s10067-017-3593-x'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s10067-017-3593-x'


 

This table displays all metadata directly associated to this object as RDF triples.

299 TRIPLES      21 PREDICATES      74 URIs      39 LITERALS      27 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s10067-017-3593-x schema:about N0df66fd1e58e4e9aa7a0acb91e356344
2 N1364375913c24484b61efca2603919e7
3 N1c047ac2c96f4090b14bd99445f9cd1a
4 N2ac8650f297b45b783bc482355a40a80
5 N45b9e5bfd3864ba3af2d171737015fe9
6 N4ed6951668d54ae594d917f757b9d46f
7 N522d2363edfc4e7b9fff9e2e5bb9dc2e
8 N5d7fa732bcfc42968e2473af6c7b2044
9 N63b934c2c5c3493d9aa5c6f07eb23414
10 N6e9e5b97f4da4538ac271725176bc2e6
11 N7ca24bb6f7c34573be80ea9c35c31959
12 N7fd1d98099e54e9fb751b8f66981cc42
13 N806c75d17ace43749f492d82bb98fe20
14 N9cd80f83a40941458266798ecb20e2a6
15 Na2e70748d2684e6ca776534a0d268b69
16 Nbf8341f7d3054b18b82827e798d63f3e
17 Ndfc594f0af71403399baf0667d667410
18 Ne5a2d48ebec849e9bc33fee5fc41b6ba
19 anzsrc-for:11
20 anzsrc-for:1103
21 schema:author Ne89834a52d2a40f99c47cf7c741373d0
22 schema:citation sg:pub.10.1038/nrrheum.2015.8
23 sg:pub.10.1186/1471-2474-10-91
24 sg:pub.10.1186/1471-2474-12-204
25 sg:pub.10.1186/ar1881
26 sg:pub.10.1186/ar3249
27 sg:pub.10.1186/s13075-015-0697-z
28 https://app.dimensions.ai/details/publication/pub.1077512807
29 https://app.dimensions.ai/details/publication/pub.1078223595
30 https://doi.org/10.1002/acr.20643
31 https://doi.org/10.1002/acr.22377
32 https://doi.org/10.1002/art.37876
33 https://doi.org/10.1002/art.37917
34 https://doi.org/10.1016/j.jaad.2005.03.046
35 https://doi.org/10.1016/j.jaad.2008.02.040
36 https://doi.org/10.1016/j.sder.2010.01.004
37 https://doi.org/10.1093/rheumatology/ken034
38 https://doi.org/10.1093/rheumatology/keq325
39 https://doi.org/10.1097/maj.0b013e3181e8bcb0
40 https://doi.org/10.1136/annrheumdis-2013-205056
41 https://doi.org/10.1136/annrheumdis-2015-208337
42 https://doi.org/10.1136/ard.2004.032482
43 https://doi.org/10.1136/rmdopen-2015-000181
44 https://doi.org/10.1155/2012/176298
45 https://doi.org/10.2147/ppa.s77053
46 https://doi.org/10.3109/14397595.2013.872862
47 https://doi.org/10.3899/jrheum.080691
48 https://doi.org/10.5312/wjo.v5.i4.537
49 schema:datePublished 2017-04
50 schema:datePublishedReg 2017-04-01
51 schema:description Psoriatic arthritis (PsA) is a chronic condition characterized by a diverse set of symptoms, from swollen joints to nail disease to skin disease. A variety of treatment options are available, including tumor necrosis factor inhibitors (TNFis). Little is known about treatment persistence in patients with PsA who initiate TNFi therapy, with and without prior biologic use. This study assessed persistence in these subgroups of patients with PsA and identified factors associated with persistence. This retrospective study utilized data from the Corrona registry of patients with PsA-with or without prior biologic experience-who initiated TNFi therapy between October 1, 2002, and March 21, 2013. Kaplan-Meier curves estimated median time to nonpersistence (discontinuation or switch to another biologic). Cox proportional hazards models identified factors associated with TNFi nonpersistence. A total of 1241 TNFi initiations were identified: 549 by biologic-naïve and 692 by biologic-experienced patients. Through 4 years of follow-up, more biologic-naïve than biologic-experienced patients remained persistent. Biologic-naïve patients had a greater mean time to nonpersistence compared with biologic-experienced patients: 32 vs 23 months (p = 0.0002). Moderate and high disease activities based on clinical disease activity index and disease duration were associated with persistence in both biologic-naïve and biologic-experienced patients. Additionally, in the biologic-experienced patients, the number of prior medications and skin disease were associated with persistence. The majority of patients with PsA in this study were persistent with their TNFi therapy; biologic-naïve patients had greater persistence compared with biologic-experienced patients. Predictors of persistence differed slightly between biologic-naïve and biologic-experienced patients.
52 schema:genre research_article
53 schema:inLanguage en
54 schema:isAccessibleForFree true
55 schema:isPartOf N12c8e4450faa49dabd69ea280d8e1b72
56 N38ebde57a9f14111bc012e14ddd19bfb
57 sg:journal.1093299
58 schema:name Impact of prior biologic use on persistence of treatment in patients with psoriatic arthritis enrolled in the US Corrona registry
59 schema:pagination 895-901
60 schema:productId N1640c5d5de9d4bb8821a25a989f7ae64
61 N439105ca02f24cb3b68be3016f477a9c
62 Neae209b04b62462a8af1ba12323b30de
63 Nf1fafececffd4f32b238180b163605ac
64 Nfff2a825a7b54c8992847202a8fe6e60
65 schema:sameAs https://app.dimensions.ai/details/publication/pub.1084023725
66 https://doi.org/10.1007/s10067-017-3593-x
67 schema:sdDatePublished 2019-04-11T09:38
68 schema:sdLicense https://scigraph.springernature.com/explorer/license/
69 schema:sdPublisher Nc7e9facfb3e743909a66e0688e9bd5e6
70 schema:url https://link.springer.com/10.1007%2Fs10067-017-3593-x
71 sgo:license sg:explorer/license/
72 sgo:sdDataset articles
73 rdf:type schema:ScholarlyArticle
74 N009b44343478403f9316d0f29699de38 rdf:first sg:person.0617012057.00
75 rdf:rest N38c5df742d6c4acfb2337296ec6af6dd
76 N05860b78372b466881e3b578306b25ad schema:name Corrona, LLC, 325 Turnpike Road, Suite 325, 01772, Southborough, MA, USA
77 Department of Epidemiology, University of Texas, MD Anderson Cancer Center, Houston, TX, USA
78 rdf:type schema:Organization
79 N0d972762fb35414592bff8d051c99695 rdf:first sg:person.014625266551.18
80 rdf:rest Nd81a176cd9834aafb7401ca0090daa10
81 N0df66fd1e58e4e9aa7a0acb91e356344 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
82 schema:name Severity of Illness Index
83 rdf:type schema:DefinedTerm
84 N1249eee7002c41ae8081a44640261e75 rdf:first sg:person.01257177671.69
85 rdf:rest rdf:nil
86 N12c8e4450faa49dabd69ea280d8e1b72 schema:issueNumber 4
87 rdf:type schema:PublicationIssue
88 N1364375913c24484b61efca2603919e7 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
89 schema:name Registries
90 rdf:type schema:DefinedTerm
91 N1640c5d5de9d4bb8821a25a989f7ae64 schema:name doi
92 schema:value 10.1007/s10067-017-3593-x
93 rdf:type schema:PropertyValue
94 N1c047ac2c96f4090b14bd99445f9cd1a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
95 schema:name Proportional Hazards Models
96 rdf:type schema:DefinedTerm
97 N2ac8650f297b45b783bc482355a40a80 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
98 schema:name Disease Progression
99 rdf:type schema:DefinedTerm
100 N38c5df742d6c4acfb2337296ec6af6dd rdf:first sg:person.014200421247.34
101 rdf:rest N4aab8d9177c844fda3bdc0e91a495685
102 N38ebde57a9f14111bc012e14ddd19bfb schema:volumeNumber 36
103 rdf:type schema:PublicationVolume
104 N439105ca02f24cb3b68be3016f477a9c schema:name pubmed_id
105 schema:value 28271234
106 rdf:type schema:PropertyValue
107 N45b9e5bfd3864ba3af2d171737015fe9 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
108 schema:name Retrospective Studies
109 rdf:type schema:DefinedTerm
110 N4aab8d9177c844fda3bdc0e91a495685 rdf:first sg:person.014444070377.20
111 rdf:rest N1249eee7002c41ae8081a44640261e75
112 N4ed6951668d54ae594d917f757b9d46f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
113 schema:name Male
114 rdf:type schema:DefinedTerm
115 N522d2363edfc4e7b9fff9e2e5bb9dc2e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
116 schema:name Arthritis, Psoriatic
117 rdf:type schema:DefinedTerm
118 N5d7fa732bcfc42968e2473af6c7b2044 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
119 schema:name Treatment Outcome
120 rdf:type schema:DefinedTerm
121 N63b934c2c5c3493d9aa5c6f07eb23414 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
122 schema:name Adult
123 rdf:type schema:DefinedTerm
124 N6e9e5b97f4da4538ac271725176bc2e6 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
125 schema:name Female
126 rdf:type schema:DefinedTerm
127 N7ca24bb6f7c34573be80ea9c35c31959 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
128 schema:name Biological Products
129 rdf:type schema:DefinedTerm
130 N7fd1d98099e54e9fb751b8f66981cc42 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
131 schema:name Kaplan-Meier Estimate
132 rdf:type schema:DefinedTerm
133 N806c75d17ace43749f492d82bb98fe20 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
134 schema:name Tumor Necrosis Factor-alpha
135 rdf:type schema:DefinedTerm
136 N950f844bff7848d3b4b7627d4742f4ad schema:name Corrona, LLC, 325 Turnpike Road, Suite 325, 01772, Southborough, MA, USA
137 rdf:type schema:Organization
138 N9cd80f83a40941458266798ecb20e2a6 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
139 schema:name Middle Aged
140 rdf:type schema:DefinedTerm
141 Na2e70748d2684e6ca776534a0d268b69 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
142 schema:name Time Factors
143 rdf:type schema:DefinedTerm
144 Nad4dddc395394e19b51239cbc18d1616 schema:name Wade Outcomes Research and Consulting, 136 U Street, 84103, Salt Lake City, UT, USA
145 rdf:type schema:Organization
146 Nb181588f37ad46d5bb6f4aee578e4513 schema:name Corrona, LLC, 325 Turnpike Road, Suite 325, 01772, Southborough, MA, USA
147 rdf:type schema:Organization
148 Nbf8341f7d3054b18b82827e798d63f3e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
149 schema:name Antirheumatic Agents
150 rdf:type schema:DefinedTerm
151 Nc2d75f5401f241a6bf2d746d6235e045 rdf:first sg:person.0747353025.27
152 rdf:rest N009b44343478403f9316d0f29699de38
153 Nc7e9facfb3e743909a66e0688e9bd5e6 schema:name Springer Nature - SN SciGraph project
154 rdf:type schema:Organization
155 Nd6253fbfc2e84eb3b91741dd6f7e9d50 rdf:first sg:person.01047467057.99
156 rdf:rest N0d972762fb35414592bff8d051c99695
157 Nd81a176cd9834aafb7401ca0090daa10 rdf:first sg:person.0643276502.79
158 rdf:rest Nc2d75f5401f241a6bf2d746d6235e045
159 Ndfc594f0af71403399baf0667d667410 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
160 schema:name Humans
161 rdf:type schema:DefinedTerm
162 Ne5a2d48ebec849e9bc33fee5fc41b6ba schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
163 schema:name United States
164 rdf:type schema:DefinedTerm
165 Ne89834a52d2a40f99c47cf7c741373d0 rdf:first sg:person.0736771744.12
166 rdf:rest Nd6253fbfc2e84eb3b91741dd6f7e9d50
167 Neae209b04b62462a8af1ba12323b30de schema:name nlm_unique_id
168 schema:value 8211469
169 rdf:type schema:PropertyValue
170 Nf1fafececffd4f32b238180b163605ac schema:name readcube_id
171 schema:value 725b50650bd89c583700db80e703ff71d4397ef69eb5c17ff2fc18958c3c7899
172 rdf:type schema:PropertyValue
173 Nfff2a825a7b54c8992847202a8fe6e60 schema:name dimensions_id
174 schema:value pub.1084023725
175 rdf:type schema:PropertyValue
176 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
177 schema:name Medical and Health Sciences
178 rdf:type schema:DefinedTerm
179 anzsrc-for:1103 schema:inDefinedTermSet anzsrc-for:
180 schema:name Clinical Sciences
181 rdf:type schema:DefinedTerm
182 sg:journal.1093299 schema:issn 0770-3198
183 1434-9949
184 schema:name Clinical Rheumatology
185 rdf:type schema:Periodical
186 sg:person.01047467057.99 schema:affiliation https://www.grid.ac/institutes/grid.417886.4
187 schema:familyName Stolshek
188 schema:givenName Bradley S.
189 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01047467057.99
190 rdf:type schema:Person
191 sg:person.01257177671.69 schema:affiliation N05860b78372b466881e3b578306b25ad
192 schema:familyName Etzel
193 schema:givenName Carol J.
194 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01257177671.69
195 rdf:type schema:Person
196 sg:person.014200421247.34 schema:affiliation Nb181588f37ad46d5bb6f4aee578e4513
197 schema:familyName Malley
198 schema:givenName Wendi
199 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014200421247.34
200 rdf:type schema:Person
201 sg:person.014444070377.20 schema:affiliation https://www.grid.ac/institutes/grid.137628.9
202 schema:familyName Greenberg
203 schema:givenName Jeffrey D.
204 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014444070377.20
205 rdf:type schema:Person
206 sg:person.014625266551.18 schema:affiliation N950f844bff7848d3b4b7627d4742f4ad
207 schema:familyName Rebello
208 schema:givenName Sabrina
209 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014625266551.18
210 rdf:type schema:Person
211 sg:person.0617012057.00 schema:affiliation Nad4dddc395394e19b51239cbc18d1616
212 schema:familyName Wade
213 schema:givenName Sally W.
214 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0617012057.00
215 rdf:type schema:Person
216 sg:person.0643276502.79 schema:affiliation https://www.grid.ac/institutes/grid.417886.4
217 schema:familyName Collier
218 schema:givenName David H.
219 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0643276502.79
220 rdf:type schema:Person
221 sg:person.0736771744.12 schema:affiliation https://www.grid.ac/institutes/grid.168645.8
222 schema:familyName Harrold
223 schema:givenName Leslie R.
224 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0736771744.12
225 rdf:type schema:Person
226 sg:person.0747353025.27 schema:affiliation https://www.grid.ac/institutes/grid.417886.4
227 schema:familyName Mutebi
228 schema:givenName Alex
229 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0747353025.27
230 rdf:type schema:Person
231 sg:pub.10.1038/nrrheum.2015.8 schema:sameAs https://app.dimensions.ai/details/publication/pub.1008800983
232 https://doi.org/10.1038/nrrheum.2015.8
233 rdf:type schema:CreativeWork
234 sg:pub.10.1186/1471-2474-10-91 schema:sameAs https://app.dimensions.ai/details/publication/pub.1039263381
235 https://doi.org/10.1186/1471-2474-10-91
236 rdf:type schema:CreativeWork
237 sg:pub.10.1186/1471-2474-12-204 schema:sameAs https://app.dimensions.ai/details/publication/pub.1007982993
238 https://doi.org/10.1186/1471-2474-12-204
239 rdf:type schema:CreativeWork
240 sg:pub.10.1186/ar1881 schema:sameAs https://app.dimensions.ai/details/publication/pub.1013480577
241 https://doi.org/10.1186/ar1881
242 rdf:type schema:CreativeWork
243 sg:pub.10.1186/ar3249 schema:sameAs https://app.dimensions.ai/details/publication/pub.1053673056
244 https://doi.org/10.1186/ar3249
245 rdf:type schema:CreativeWork
246 sg:pub.10.1186/s13075-015-0697-z schema:sameAs https://app.dimensions.ai/details/publication/pub.1012494697
247 https://doi.org/10.1186/s13075-015-0697-z
248 rdf:type schema:CreativeWork
249 https://app.dimensions.ai/details/publication/pub.1077512807 schema:CreativeWork
250 https://app.dimensions.ai/details/publication/pub.1078223595 schema:CreativeWork
251 https://doi.org/10.1002/acr.20643 schema:sameAs https://app.dimensions.ai/details/publication/pub.1030584108
252 rdf:type schema:CreativeWork
253 https://doi.org/10.1002/acr.22377 schema:sameAs https://app.dimensions.ai/details/publication/pub.1044199186
254 rdf:type schema:CreativeWork
255 https://doi.org/10.1002/art.37876 schema:sameAs https://app.dimensions.ai/details/publication/pub.1042418966
256 rdf:type schema:CreativeWork
257 https://doi.org/10.1002/art.37917 schema:sameAs https://app.dimensions.ai/details/publication/pub.1004625809
258 rdf:type schema:CreativeWork
259 https://doi.org/10.1016/j.jaad.2005.03.046 schema:sameAs https://app.dimensions.ai/details/publication/pub.1038933125
260 rdf:type schema:CreativeWork
261 https://doi.org/10.1016/j.jaad.2008.02.040 schema:sameAs https://app.dimensions.ai/details/publication/pub.1050660676
262 rdf:type schema:CreativeWork
263 https://doi.org/10.1016/j.sder.2010.01.004 schema:sameAs https://app.dimensions.ai/details/publication/pub.1054747839
264 rdf:type schema:CreativeWork
265 https://doi.org/10.1093/rheumatology/ken034 schema:sameAs https://app.dimensions.ai/details/publication/pub.1000685889
266 rdf:type schema:CreativeWork
267 https://doi.org/10.1093/rheumatology/keq325 schema:sameAs https://app.dimensions.ai/details/publication/pub.1038859738
268 rdf:type schema:CreativeWork
269 https://doi.org/10.1097/maj.0b013e3181e8bcb0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1009052293
270 rdf:type schema:CreativeWork
271 https://doi.org/10.1136/annrheumdis-2013-205056 schema:sameAs https://app.dimensions.ai/details/publication/pub.1004467907
272 rdf:type schema:CreativeWork
273 https://doi.org/10.1136/annrheumdis-2015-208337 schema:sameAs https://app.dimensions.ai/details/publication/pub.1022767391
274 rdf:type schema:CreativeWork
275 https://doi.org/10.1136/ard.2004.032482 schema:sameAs https://app.dimensions.ai/details/publication/pub.1002609767
276 rdf:type schema:CreativeWork
277 https://doi.org/10.1136/rmdopen-2015-000181 schema:sameAs https://app.dimensions.ai/details/publication/pub.1023074542
278 rdf:type schema:CreativeWork
279 https://doi.org/10.1155/2012/176298 schema:sameAs https://app.dimensions.ai/details/publication/pub.1029767398
280 rdf:type schema:CreativeWork
281 https://doi.org/10.2147/ppa.s77053 schema:sameAs https://app.dimensions.ai/details/publication/pub.1046367370
282 rdf:type schema:CreativeWork
283 https://doi.org/10.3109/14397595.2013.872862 schema:sameAs https://app.dimensions.ai/details/publication/pub.1052494762
284 rdf:type schema:CreativeWork
285 https://doi.org/10.3899/jrheum.080691 schema:sameAs https://app.dimensions.ai/details/publication/pub.1071541588
286 rdf:type schema:CreativeWork
287 https://doi.org/10.5312/wjo.v5.i4.537 schema:sameAs https://app.dimensions.ai/details/publication/pub.1072758487
288 rdf:type schema:CreativeWork
289 https://www.grid.ac/institutes/grid.137628.9 schema:alternateName New York University
290 schema:name Corrona, LLC, 325 Turnpike Road, Suite 325, 01772, Southborough, MA, USA
291 New York University School of Medicine, 301 East 17th Street, Suite 1410, 10003, New York, NY, USA
292 rdf:type schema:Organization
293 https://www.grid.ac/institutes/grid.168645.8 schema:alternateName University of Massachusetts Medical School
294 schema:name Corrona, LLC, 325 Turnpike Road, Suite 325, 01772, Southborough, MA, USA
295 Department of Medicine, University of Massachusetts Medical School, AC7-201, 55 Lake Avenue North, 01655, Worcester, MA, USA
296 rdf:type schema:Organization
297 https://www.grid.ac/institutes/grid.417886.4 schema:alternateName Amgen (United States)
298 schema:name Amgen Inc., One Amgen Center Drive, 91320, Thousand Oaks, CA, USA
299 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...